2023-2027 年 BCL-2（B 细胞淋巴瘤 2）抑製剂的全球市场

Technavio预测，2022-2027年BCL-2（B细胞淋巴瘤2）抑製剂市场规模有望增加16.5708亿美元，预计年復合增长率为12.92%在

本报告对 BCL-2（B 细胞淋巴瘤 2）抑製剂市场、市场规模/预测、趋势、增长驱动因素/挑战以及涵盖约 25 家供应商的供应商分析进行了全面分析。

我们提供对当前市场情景、最新趋势和驱动因素以及整体市场环境的最新分析。 老年人口的增长、对血液系统恶性肿瘤的认识不断提高以及 BCL-2 抑製剂的高靶标亲和力和特异性推动了市场的发展。

这项研究确定患者援助计划的增加是未来几年推动 BCL-2（B 细胞淋巴瘤 2）抑製剂市场增长的关键原因之一。 此外，联合疗法的批准进展和新製剂的开发预计将导致巨大的市场需求。

内容

第 1 章执行摘要

• 市场概览

第二章市场状况

• 市场生态系统

第三章市场规模

• 市场定义
• 市场细分分析
• 2022 年市场规模
• 市场展望：2022-2027 年预测

第 4 章市场规模结果

• 2017-2021 年全球 BCL-2（B 细胞淋巴瘤 2）抑製剂市场
• 2017-2021 年产品细分分析
• 2017-2021 年类型细分分析
• 2017-2021 年区域细分分析
• 2017-2021 年国家/地区细分分析

第五章五力分析

• 五力总结
• 买家的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场

第 6 章按产品细分市场

• 市场细分
• 产品比较
• 联合疗法 - 2022-2027 年市场规模和预测
• 单一疗法 – 2022 年至 2027 年的市场规模和预测
• 按产品分类的市场机会

第 7 章按类型划分的市场

• 市场细分
• 按类型比较
• 瀰漫性大 B 细胞淋巴瘤 (DLBCL) – 市场规模和 2022-2027 年预测
• 滤泡性淋巴瘤 - 2022-2027 年市场规模和预测
• 慢性淋巴细胞白血病 - 2022-2027 年市场规模和预测
• 套细胞淋巴瘤 (MCL) - 2022-2027 年市场规模和预测
• 按类型划分的市场机会

第八章客户情况

• 客户情况总结

第九章区域情况

• 区域细分
• 按地区比较
• 北美 - 2022-2027 年市场规模和预测
• 欧洲 - 2022 年至 2027 年的市场规模和预测
• 亚洲 – 2022-2027 年市场规模和预测
• 世界其他地区 (ROW) – 市场规模和 2022-2027 年预测
• 美国 - 2022-2027 年市场规模和预测
• 加拿大 - 2022-2027 年市场规模和预测
• 德国 - 2022-2027 年市场规模和预测
• 英国 - 2022-2027 年市场规模和预测
• 法国 - 2022-2027 年市场规模和预测
• 各地区的市场机会

第 10 章驱动因素、挑战和趋势

• 市场驱动力
• 市场挑战
• 挑战的驱动因素和影响
• 市场趋势

第 11 章供应商概况

• 概览
• 供应商情况
• 混乱情况
• 行业风险

第 12 章供应商分析

• 目标供应商
• 供应商市场定位
• AbbVie Inc.
• Abcam plc
• Amgen Inc.
• Ascentage Pharma Group International
• AstraZeneca Plc
• BeiGene Ltd.
• Bio Techne Corp.
• Biorbyt Ltd.
• Bristol Myers Squibb Co.
• F. Hoffmann La Roche Ltd.
• Merck and Co. Inc.
• Novartis AG
• Santa Cruz Biotechnology Inc.
• Seagen Inc.
• Servier

第13章 附录

Technavio has been monitoring the BCL-2 (B-cell Lymphoma 2) inhibitors market and is forecast to grow by $1,657.08 mn during 2022-2027, accelerating at a CAGR of 12.92% during the forecast period. Our report on the BCL-2 (B-cell Lymphoma 2)inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population, growing awareness about hematological malignancies, and high target affinity and specificity of BCL-2 inhibitors.

Technavio's BCL-2 (B-cell Lymphoma 2) inhibitors market is segmented as below:

By Product

• Combination therapy
• Monotherapy

By Type

• Diffuse large B-cell lymphoma (DLBCL)
• Follicular lymphoma
• Chronic lymphocytic leukemia
• Mantle cell lymphoma (MCL)

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase of patient assistance programs as one of the prime reasons driving the BCL-2 (B-cell Lymphoma 2) inhibitors market growth during the next few years. Also, growing approval of combination therapy and development of novel formulations will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the BCL-2 (B-cell Lymphoma 2) inhibitors market covers the following areas:

• BCL-2 (B-cell Lymphoma 2) inhibitors market sizing
• BCL-2 (B-cell Lymphoma 2) inhibitors market forecast
• BCL-2 (B-cell Lymphoma 2) inhibitors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading BCL-2 (B-cell Lymphoma 2) inhibitors market vendors that include Abcam plc, Amgen Inc., Ascentage Pharma Group International, AstraZeneca Plc, BeiGene Ltd., Bio Techne Corp., Biorbyt Ltd., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Santa Cruz Biotechnology Inc., Seagen Inc., Servier, and AbbVie Inc. Also, the BCL-2 (B-cell Lymphoma 2) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 - 2021 ($ million)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Combination therapy - Market size and forecast 2022-2027
• Exhibit 34: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
• 6.4 Monotherapy - Market size and forecast 2022-2027
• Exhibit 38: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 44: Chart on Type - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 46: Chart on Comparison by Type
• Exhibit 47: Data Table on Comparison by Type
• 7.3 Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2022-2027
• Exhibit 48: Chart on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2022-2027 (%)
• 7.4 Follicular lymphoma - Market size and forecast 2022-2027
• Exhibit 52: Chart on Follicular lymphoma - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Follicular lymphoma - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Follicular lymphoma - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Follicular lymphoma - Year-over-year growth 2022-2027 (%)
• 7.5 Chronic lymphocytic leukemia - Market size and forecast 2022-2027
• Exhibit 56: Chart on Chronic lymphocytic leukemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Chronic lymphocytic leukemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Chronic lymphocytic leukemia - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Chronic lymphocytic leukemia - Year-over-year growth 2022-2027 (%)
• 7.6 Mantle cell lymphoma (MCL) - Market size and forecast 2022-2027
• Exhibit 60: Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Mantle cell lymphoma (MCL) - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Mantle cell lymphoma (MCL) - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Type
• Exhibit 64: Market opportunity by Type ($ million)
• Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 France - Market size and forecast 2022-2027
• Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 115: AbbVie Inc. - Overview
• Exhibit 116: AbbVie Inc. - Product / Service
• Exhibit 117: AbbVie Inc. - Key news
• Exhibit 118: AbbVie Inc. - Key offerings
• 12.4 Abcam plc
• Exhibit 119: Abcam plc - Overview
• Exhibit 120: Abcam plc - Product / Service
• Exhibit 121: Abcam plc - Key news
• Exhibit 122: Abcam plc - Key offerings
• 12.5 Amgen Inc.
• Exhibit 123: Amgen Inc. - Overview
• Exhibit 124: Amgen Inc. - Product / Service
• Exhibit 125: Amgen Inc. - Key offerings
• 12.6 Ascentage Pharma Group International
• Exhibit 126: Ascentage Pharma Group International - Overview
• Exhibit 127: Ascentage Pharma Group International - Product / Service
• Exhibit 128: Ascentage Pharma Group International - Key offerings
• 12.7 AstraZeneca Plc
• Exhibit 129: AstraZeneca Plc - Overview
• Exhibit 130: AstraZeneca Plc - Product / Service
• Exhibit 131: AstraZeneca Plc - Key news
• Exhibit 132: AstraZeneca Plc - Key offerings
• 12.8 BeiGene Ltd.
• Exhibit 133: BeiGene Ltd. - Overview
• Exhibit 134: BeiGene Ltd. - Business segments
• Exhibit 135: BeiGene Ltd. - Key offerings
• Exhibit 136: BeiGene Ltd. - Segment focus
• 12.9 Bio Techne Corp.
• Exhibit 137: Bio Techne Corp. - Overview
• Exhibit 138: Bio Techne Corp. - Business segments
• Exhibit 139: Bio Techne Corp. - Key news
• Exhibit 140: Bio Techne Corp. - Key offerings
• Exhibit 141: Bio Techne Corp. - Segment focus
• 12.10 Biorbyt Ltd.
• Exhibit 142: Biorbyt Ltd. - Overview
• Exhibit 143: Biorbyt Ltd. - Product / Service
• Exhibit 144: Biorbyt Ltd. - Key offerings
• 12.11 Bristol Myers Squibb Co.
• Exhibit 145: Bristol Myers Squibb Co. - Overview
• Exhibit 146: Bristol Myers Squibb Co. - Product / Service
• Exhibit 147: Bristol Myers Squibb Co. - Key news
• Exhibit 148: Bristol Myers Squibb Co. - Key offerings
• 12.12 F. Hoffmann La Roche Ltd.
• Exhibit 149: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 150: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 151: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 152: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 153: F. Hoffmann La Roche Ltd. - Segment focus
• 12.13 Merck and Co. Inc.
• Exhibit 154: Merck and Co. Inc. - Overview
• Exhibit 155: Merck and Co. Inc. - Business segments
• Exhibit 156: Merck and Co. Inc. - Key news
• Exhibit 157: Merck and Co. Inc. - Key offerings
• Exhibit 158: Merck and Co. Inc. - Segment focus
• 12.14 Novartis AG
• Exhibit 159: Novartis AG - Overview
• Exhibit 160: Novartis AG - Business segments
• Exhibit 161: Novartis AG - Key offerings
• Exhibit 162: Novartis AG - Segment focus
• 12.15 Santa Cruz Biotechnology Inc.
• Exhibit 163: Santa Cruz Biotechnology Inc. - Overview
• Exhibit 164: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibit 165: Santa Cruz Biotechnology Inc. - Key offerings
• 12.16 Seagen Inc.
• Exhibit 166: Seagen Inc. - Overview
• Exhibit 167: Seagen Inc. - Product / Service
• Exhibit 168: Seagen Inc. - Key offerings
• 12.17 Servier
• Exhibit 169: Servier - Overview
• Exhibit 170: Servier - Business segments
• Exhibit 171: Servier - Key offerings
• Exhibit 172: Servier - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 173: Inclusions checklist
• Exhibit 174: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 175: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 176: Research methodology
• Exhibit 177: Validation techniques employed for market sizing
• Exhibit 178: Information sources
• 13.5 List of abbreviations
• Exhibit 179: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Product ($ million)
• Exhibits43: Data Table on Market opportunity by Product ($ million)
• Exhibits44: Chart on Type - Market share 2022-2027 (%)
• Exhibits45: Data Table on Type - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Type
• Exhibits47: Data Table on Comparison by Type
• Exhibits48: Chart on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Follicular lymphoma - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Follicular lymphoma - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Follicular lymphoma - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Follicular lymphoma - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Chronic lymphocytic leukemia - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Chronic lymphocytic leukemia - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Chronic lymphocytic leukemia - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Chronic lymphocytic leukemia - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Mantle cell lymphoma (MCL) - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Mantle cell lymphoma (MCL) - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by Type ($ million)
• Exhibits65: Data Table on Market opportunity by Type ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share by geography 2022-2027 (%)
• Exhibits68: Data Table on Market share by geography 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits107: Market opportunity by geography ($ million)
• Exhibits108: Data Tables on Market opportunity by geography ($ million)
• Exhibits109: Impact of drivers and challenges in 2022 and 2027
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: AbbVie Inc. - Overview
• Exhibits116: AbbVie Inc. - Product / Service
• Exhibits117: AbbVie Inc. - Key news
• Exhibits118: AbbVie Inc. - Key offerings
• Exhibits119: Abcam plc - Overview
• Exhibits120: Abcam plc - Product / Service
• Exhibits121: Abcam plc - Key news
• Exhibits122: Abcam plc - Key offerings
• Exhibits123: Amgen Inc. - Overview
• Exhibits124: Amgen Inc. - Product / Service
• Exhibits125: Amgen Inc. - Key offerings
• Exhibits126: Ascentage Pharma Group International - Overview
• Exhibits127: Ascentage Pharma Group International - Product / Service
• Exhibits128: Ascentage Pharma Group International - Key offerings
• Exhibits129: AstraZeneca Plc - Overview
• Exhibits130: AstraZeneca Plc - Product / Service
• Exhibits131: AstraZeneca Plc - Key news
• Exhibits132: AstraZeneca Plc - Key offerings
• Exhibits133: BeiGene Ltd. - Overview
• Exhibits134: BeiGene Ltd. - Business segments
• Exhibits135: BeiGene Ltd. - Key offerings
• Exhibits136: BeiGene Ltd. - Segment focus
• Exhibits137: Bio Techne Corp. - Overview
• Exhibits138: Bio Techne Corp. - Business segments
• Exhibits139: Bio Techne Corp. - Key news
• Exhibits140: Bio Techne Corp. - Key offerings
• Exhibits141: Bio Techne Corp. - Segment focus
• Exhibits142: Biorbyt Ltd. - Overview
• Exhibits143: Biorbyt Ltd. - Product / Service
• Exhibits144: Biorbyt Ltd. - Key offerings
• Exhibits145: Bristol Myers Squibb Co. - Overview
• Exhibits146: Bristol Myers Squibb Co. - Product / Service
• Exhibits147: Bristol Myers Squibb Co. - Key news
• Exhibits148: Bristol Myers Squibb Co. - Key offerings
• Exhibits149: F. Hoffmann La Roche Ltd. - Overview
• Exhibits150: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits151: F. Hoffmann La Roche Ltd. - Key news
• Exhibits152: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits153: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits154: Merck and Co. Inc. - Overview
• Exhibits155: Merck and Co. Inc. - Business segments
• Exhibits156: Merck and Co. Inc. - Key news
• Exhibits157: Merck and Co. Inc. - Key offerings
• Exhibits158: Merck and Co. Inc. - Segment focus
• Exhibits159: Novartis AG - Overview
• Exhibits160: Novartis AG - Business segments
• Exhibits161: Novartis AG - Key offerings
• Exhibits162: Novartis AG - Segment focus
• Exhibits163: Santa Cruz Biotechnology Inc. - Overview
• Exhibits164: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibits165: Santa Cruz Biotechnology Inc. - Key offerings
• Exhibits166: Seagen Inc. - Overview
• Exhibits167: Seagen Inc. - Product / Service
• Exhibits168: Seagen Inc. - Key offerings
• Exhibits169: Servier - Overview
• Exhibits170: Servier - Business segments
• Exhibits171: Servier - Key offerings
• Exhibits172: Servier - Segment focus
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Information sources
• Exhibits179: List of abbreviations